These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 31050611

  • 1. Defining a Liver Transplant Benefit Threshold for the Model for End-Stage Liver Disease-Sodium Score.
    Beal EW, Akateh C, Tumin D, Bagante F, Black SM, Washburn K, Azouley D, Pawlik TM.
    Exp Clin Transplant; 2020 Aug; 18(4):491-497. PubMed ID: 31050611
    [Abstract] [Full Text] [Related]

  • 2. Serum sodium and survival benefit of liver transplantation.
    Sharma P, Schaubel DE, Goodrich NP, Merion RM.
    Liver Transpl; 2015 Mar; 21(3):308-13. PubMed ID: 25504743
    [Abstract] [Full Text] [Related]

  • 3. MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era.
    Kim WR, Mannalithara A, Heimbach JK, Kamath PS, Asrani SK, Biggins SW, Wood NL, Gentry SE, Kwong AJ.
    Gastroenterology; 2021 Dec; 161(6):1887-1895.e4. PubMed ID: 34481845
    [Abstract] [Full Text] [Related]

  • 4. Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk.
    Somsouk M, Kornfield R, Vittinghoff E, Inadomi JM, Biggins SW.
    Liver Transpl; 2011 Feb; 17(2):129-36. PubMed ID: 21280185
    [Abstract] [Full Text] [Related]

  • 5. A revised model for end-stage liver disease optimizes prediction of mortality among patients awaiting liver transplantation.
    Leise MD, Kim WR, Kremers WK, Larson JJ, Benson JT, Therneau TM.
    Gastroenterology; 2011 Jun; 140(7):1952-60. PubMed ID: 21334338
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality.
    Yamashiki N, Sugawara Y, Tamura S, Kaneko J, Nojiri K, Aoki T, Sakamoto Y, Hasegawa K, Koike K, Kokudo N.
    Transplant Proc; 2012 Mar; 44(2):389-92. PubMed ID: 22410024
    [Abstract] [Full Text] [Related]

  • 8. MELD-XI Score and Coronary Artery Disease Prevalence and Extent Among In-Hospital Patients With End-Stage Liver Failure Awaiting Transplant.
    Keskin S, Çiftci O, Moray G, Müderrisoğlu H, Haberal M.
    Exp Clin Transplant; 2020 Jan; 18(Suppl 1):88-92. PubMed ID: 32008505
    [Abstract] [Full Text] [Related]

  • 9. End-stage liver disease candidates at the highest model for end-stage liver disease scores have higher wait-list mortality than status-1A candidates.
    Sharma P, Schaubel DE, Gong Q, Guidinger M, Merion RM.
    Hepatology; 2012 Jan; 55(1):192-8. PubMed ID: 21898487
    [Abstract] [Full Text] [Related]

  • 10. Factors that affect deceased donor liver transplantation rates in the United States in addition to the Model for End-stage Liver Disease score.
    Sharma P, Schaubel DE, Messersmith EE, Guidinger MK, Merion RM.
    Liver Transpl; 2012 Dec; 18(12):1456-63. PubMed ID: 22965903
    [Abstract] [Full Text] [Related]

  • 11. Revision of MELD to include serum albumin improves prediction of mortality on the liver transplant waiting list.
    Myers RP, Shaheen AA, Faris P, Aspinall AI, Burak KW.
    PLoS One; 2013 Dec; 8(1):e51926. PubMed ID: 23349678
    [Abstract] [Full Text] [Related]

  • 12. Survival Benefit of Living-Donor Liver Transplant.
    Jackson WE, Malamon JS, Kaplan B, Saben JL, Schold JD, Pomposelli JJ, Pomfret EA.
    JAMA Surg; 2022 Oct 01; 157(10):926-932. PubMed ID: 35921119
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The von Willebrand Factor Facilitates Model for End-Stage Liver Disease-Independent Risk Stratification on the Waiting List for Liver Transplantation.
    Györi GP, Pereyra D, Rumpf B, Hackl H, Köditz C, Ortmayr G, Reiberger T, Trauner M, Berlakovich GA, Starlinger P.
    Hepatology; 2020 Aug 01; 72(2):584-594. PubMed ID: 31773739
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy.
    Gadiparthi C, Cholankeril G, Yoo ER, Hu M, Wong RJ, Ahmed A.
    Dig Dis Sci; 2018 Jun 01; 63(6):1647-1653. PubMed ID: 29611079
    [Abstract] [Full Text] [Related]

  • 17. Effects of Allocating Livers for Transplantation Based on Model for End-Stage Liver Disease-Sodium Scores on Patient Outcomes.
    Nagai S, Chau LC, Schilke RE, Safwan M, Rizzari M, Collins K, Yoshida A, Abouljoud MS, Moonka D.
    Gastroenterology; 2018 Nov 01; 155(5):1451-1462.e3. PubMed ID: 30056096
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Model for End-Stage Liver Disease and Seven Derivations to Prioritize Liver Transplant Candidates: Which Is the Winner?
    Tohidinezhad F, Eslami S, Abu-Hanna A, Aliakbarian M.
    Exp Clin Transplant; 2018 Dec 01; 16(6):721-729. PubMed ID: 29457445
    [Abstract] [Full Text] [Related]

  • 20. MELD scores with incorporation of serum sodium and death prediction in cirrhotic patients on the waiting list for liver transplantation: a single center experience in southern Brazil.
    Marroni CP, de Mello Brandão AB, Hennigen AW, Marroni C, Zanotelli ML, Cantisani G, Fuchs SC, Liver Transplantation Group.
    Clin Transplant; 2012 Dec 01; 26(4):E395-401. PubMed ID: 22882694
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.